| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 The Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois; 2 Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts; 3 Molecular Evolution Group, Institute of Molecular Biology, University of Copenhagen, Copenhagen, Denmark; 4 Center for Experimental Bioinformatics, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; and 5 The Toyota Technological Institute at Chicago, Chicago, Illinois
Requests for reprints: Marcus E. Peter, The Ben May Department for Cancer Research, The University of Chicago, 924 East 57th Street, R112, Chicago, IL 60637. Phone: 773-702-4728; Fax: 773-702-3701; E-mail: mpeter{at}uchicago.edu.
Key Words: cancer progression IMP-1 miRNA
MicroRNAs (miRNA) are small RNA molecules of
20 to 22 nucleotides that reduce expression of proteins through mRNA degradation and/or translational silencing. Each known miRNA has a large number of predicted targets. Members of the let-7/miR-98 family of miRNAs are up-regulated at the end of embryonic development. Let-7 is often down-regulated early during cancer development, suggesting that let-7–regulated oncofetal genes (LOG) may become reexpressed in cancer cells. Using comparative bioinformatics, we have identified 12 conserved LOGs that include HMGA2 and IMP-1/CRD-BP. IMP-1 has growth-promoting activities through stabilization of c-myc mRNA. We experimentally confirmed that IMP-1 is a direct let-7 target that promotes cell growth and motility of tumor cells, and we confirmed by proteomics analysis that IMP-1 and HMGA2 are major miRNA targets. Our data suggest that a substantial part of the growth inhibitory activities of let-7 comes from suppressing the expression of IMP-1. LOGs could be novel therapeutic targets and potential biomarkers for cancer treatment. [Cancer Res 2008;68(8):2587–91]
This article has been cited by other articles:
![]() |
P. Bhat-Nakshatri, G. Wang, N. R. Collins, M. J. Thomson, T. R. Geistlinger, J. S. Carroll, M. Brown, S. Hammond, E. F. Srour, Y. Liu, et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells Nucleic Acids Res., August 1, 2009; 37(14): 4850 - 4861. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Du, J. J. Schageman, M. C. Subauste, B. Saber, S. M. Hammond, L. Prudkin, I. I. Wistuba, L. Ji, J. A. Roth, J. D. Minna, et al. miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1 Mol. Cancer Res., August 1, 2009; 7(8): 1234 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sun, M. Fu, A. L. Bookout, S. A. Kliewer, and D. J. Mangelsdorf MicroRNA let-7 Regulates 3T3-L1 Adipogenesis Mol. Endocrinol., June 1, 2009; 23(6): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Childs, M. Fazzari, G. Kung, N. Kawachi, M. Brandwein-Gensler, M. McLemore, Q. Chen, R. D. Burk, R. V. Smith, M. B. Prystowsky, et al. Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma Am. J. Pathol., March 1, 2009; 174(3): 736 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, S. Kaur, S. Volinia, J. Greshock, H. Lassus, K. Hasegawa, S. Liang, A. Leminen, S. Deng, L. Smith, et al. MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer Cancer Res., December 15, 2008; 68(24): 10307 - 10314. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |